World Heart Federation Roadmap for Heart Failure

Ferreira, João Pedro; Kraus, Sarah; Mitchell, Sharon; Perel, Pablo; Piñeiro, Daniel; Chioncel, Ovidiu; Colque, Roberto; Boer, Rudolf A. de; Gómez-Mesa, Juan Esteban; Grancelli, Hugo; Lam, Carolyn S.P.; Martínez‐Rubio, Antoni; McMurray, John J.V.; Mebazaa, Alexandre; Panjrath, Gurusher; Piña, Ileana L.; Sani, Mahmoud U; Sim, David; Walsh, Mary Norine; Yancy, Clyde W.; Zannad, Faı̈ez; Sliwa, Karen

doi:10.1016/j.gheart.2019.07.004

Cited by 76 publications

(67 citation statements)

References 102 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Primary outcomes included all-cause mortality, readmission, emergency department (ED) visits, lengths of hospital stays, and QoL [1,[21][22][23]. Secondary outcomes were self-care behaviors, including medication adherence and other clinical outcomes [24,25]. IG scored significantly lower on hospitalization (p = 0.03), readmission (p = 0.03), hospital days (p = 0.01); no significant difference in ED visits.…”

Section: Data Extractionmentioning

confidence: 99%

Effectiveness of Mobile Phone-Based Interventions for Improving Health Outcomes in Patients with Chronic Heart Failure: A Systematic Review and Meta-Analysis

Son

Lee

2020

IJERPH

View full text Add to dashboard Cite

Mobile phone-based interventions are increasingly used to prevent adverse health outcomes in heart failure patients. However, the effects of mobile phone-based interventions on the health outcomes of heart failure patients remain unclear. Our review aims to synthesize the randomized controlled trials (RCT) of mobile phone-based interventions for heart failure patients and identify the intervention features that are most effective. Electronic searches of RCTs published from January 2000 to July 2019 were conducted. Primary outcomes included all-cause mortality, readmission, emergency department visits, length of hospital stays, and quality of life. Secondary outcomes were self-care behaviors, including medication adherence and other clinical outcomes. A total of eight studies with varying methodological quality met the inclusion criteria and were analyzed. Voice call intervention was more frequently used compared with telemonitoring and short message services. Our meta-analysis showed that voice call interventions had significant effects on the length of hospital stays. However, no significant effects on all-cause mortality, readmission, emergency department visits, or quality of life were found. Compared to other mobile phone-based interventions, voice calls were more effective in reducing the length of hospital stay. Future studies are needed to identify which features of mobile phone-based intervention most effectively improve health outcomes.

show abstract

Section: Data Extractionmentioning

confidence: 99%

Effectiveness of Mobile Phone-Based Interventions for Improving Health Outcomes in Patients with Chronic Heart Failure: A Systematic Review and Meta-Analysis

Son

Lee

2020

IJERPH

View full text Add to dashboard Cite

show abstract

“…Despite these advances, it is likely that spironolactone will remain the most widely used MRA, mainly because it is affordable, widely available, and with a large and long clinical experience. 32 Still, MRAs are generally underused, even in populations who might experience great benefit. 33 With regard to dose adaptations, and until further evidence is available, it seems reasonable to adapt the spironolactone dose according to renal function and K + levels based on an algorithm that has been used in clinical trials (online supplementary Table S8).…”

Section: Discussionmentioning

confidence: 99%

Spironolactone dose in heart failure with preserved ejection fraction: findings from TOPCAT

Ferreira

Rosselló

Pocock

et al. 2020

European J of Heart Fail

Self Cite

View full text Add to dashboard Cite

Spironolactone up-titration may be limited by side effects that could be minimized at lower than target doses, but whether lower than target doses remain efficacious is unknown. In TOPCAT, spironolactone (or placebo) were started at 15 mg/day, and increased up to a maximum of 45 mg/day. The prognostic implications related to spironolactone dose are yet to be reported. We aimed to assess the average spironolactone/placebo doses provided during the trial, overall and within high-risk subgroups (e.g. elderly, renal dysfunction, high potassium); discontinuation rates; and the efficacy of lower than target doses in heart failure with preserved ejection fraction.

show abstract

“…Heart failure is now the world's leading cause of hospitalisation according to Ferreira et al (2019). Hospitalisations account for the high cost of treating heart failure, which comprises almost 2% of the NHS budget (National Confidential Enquiry into Patient Outcome and Death [NCEPOD], 2018); 60-70% of those costs are because of hospital admissions.…”

Section: Introductionmentioning

confidence: 99%

Increasing the heart failure nursing workforce: recommendations by the British Society for Heart Failure Nurse Forum

Masters

Barton

Blue

et al. 2019

British Journal of Cardiac Nursing

View full text Add to dashboard Cite

There are almost 1 million people diagnosed with heart failure in the UK, and this number continues to rise. It is a common cause of hospitalisation and costs associated with those hospitalisations account for a significant proportion of the NHS budget. Studies have demonstrated that community heart failure specialist nurses improve patient outcomes and reduce the costs associated with hospitalisation. Yet, despite increased prevalence, considerable advances in therapies, and new recommendations from the National Institute for Health and Care Excellence, the recommended number of heart failure specialist nurses per 100 000 has stayed the same. This article will describe the development of community heart failure nursing in the UK, and outline the challenges currently facing heart failure specialist nurses. It makes a number of recommendations that would ensure heart failure patients are able to be seen by a heart failure specialist nurse in a timely manner, help reduce inequalities of care, reduce costs associated with heart failure hospitalisations and help ensure sustainability of heart failure services over the longer term.

show abstract

World Heart Federation Roadmap for Heart Failure

Cited by 76 publications

References 102 publications

Effectiveness of Mobile Phone-Based Interventions for Improving Health Outcomes in Patients with Chronic Heart Failure: A Systematic Review and Meta-Analysis

Effectiveness of Mobile Phone-Based Interventions for Improving Health Outcomes in Patients with Chronic Heart Failure: A Systematic Review and Meta-Analysis

Spironolactone dose in heart failure with preserved ejection fraction: findings from TOPCAT

Increasing the heart failure nursing workforce: recommendations by the British Society for Heart Failure Nurse Forum

Contact Info

Product

Resources

About